420 related articles for article (PubMed ID: 33741347)
21. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
22. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
Pacheco MC; Dolan M; Bendel A
Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
[TBL] [Abstract][Full Text] [Related]
23. Poorly Differentiated Chordoma of the Clivus With Loss of SMARCB1 Expression in a Pediatric Patient: A Case Report.
Yasue S; Ozeki M; Endo S; Kanayama T; Suzui N; Nakamura S; Kishimoto K; Kosaka Y; Miyazaki T; Demizu Y; Soejima T; Kawamura A; Ohnishi H
J Pediatr Hematol Oncol; 2022 Nov; 44(8):465-470. PubMed ID: 35091519
[TBL] [Abstract][Full Text] [Related]
24. Intracranial atypical teratoid/rhabdoid tumor presenting as an axillary mass: a case report and review of literature.
Bush JW; Hancock B; Israels SJ; Ellison DW; Stefanovici C; Krawitz S
Pediatr Dev Pathol; 2014; 17(2):122-5. PubMed ID: 24555876
[TBL] [Abstract][Full Text] [Related]
25. TLE1 Expression in Malignant Rhabdoid Tumor and Atypical Teratoid/Rhabdoid Tumor.
Duncan VE; Wicker JA; Kelly DR; Li R
Pediatr Dev Pathol; 2018; 21(6):522-527. PubMed ID: 29490565
[TBL] [Abstract][Full Text] [Related]
26. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
[TBL] [Abstract][Full Text] [Related]
27. Atypical teratoid/rhabdoid tumor of the central nervous system: clinicopathologic and immunohistochemical features of four cases.
Ertan Y; Sezak M; Turhan T; Kantar M; Erşahin Y; Mutluer S; Vergin C; Oniz H; Akalin T
Childs Nerv Syst; 2009 Jun; 25(6):707-11. PubMed ID: 19212771
[TBL] [Abstract][Full Text] [Related]
28. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.
Deisch J; Raisanen J; Rakheja D
Pediatr Dev Pathol; 2011; 14(5):353-9. PubMed ID: 21417895
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological features of notochordal tumors: a study of 48 cases].
Huang J; Yang TT; Jiang ZM; Zhang HZ
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):201-206. PubMed ID: 33677882
[No Abstract] [Full Text] [Related]
31. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
32. Primary Intracranial Atypical Teratoid/Rhabdoid Tumors: A Clinicopathologic and Neuroradiologic Study.
Zhao RJ; Wu KY; Zhang JG; Ma YH; Kong LF
J Child Neurol; 2015 Jul; 30(8):1017-23. PubMed ID: 25323739
[TBL] [Abstract][Full Text] [Related]
33. Chordoma: Immunohistochemical Analysis of Brachury.
Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
[TBL] [Abstract][Full Text] [Related]
34. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
[TBL] [Abstract][Full Text] [Related]
35. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.
Sangoi AR; Karamchandani J; Lane B; Higgins JP; Rouse RV; Brooks JD; McKenney JK
Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418
[TBL] [Abstract][Full Text] [Related]
36. Poorly differentiated SMARCB1/INI1-negative chordomas.
Zhao J; Feng J; Chen L; Ma Y; Ding D; Wang H
Clin Neuropathol; 2021; 40(1):36-45. PubMed ID: 32631481
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
[TBL] [Abstract][Full Text] [Related]
38. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
[TBL] [Abstract][Full Text] [Related]
39. Patterns of brachyury expression in chordomas.
Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961
[TBL] [Abstract][Full Text] [Related]
40. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC
Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
